Circulating HPV Tumor DNA and Molecular Residual Disease in HPV-Positive Oropharyngeal Cancers: A Scoping Review

Circulating HPV Tumor DNA and Molecular Residual Disease in HPV-Positive Oropharyngeal Cancers: A Scoping Review

The aim of this review is to assess the utility of circulating HPV tumor DNA (ctHPVDNA) clearance in the monitoring of molecular residual disease in HPV-related oropharyngeal squamous cell carcinoma (OPSCC) patients. Recently, ctHPVDNA in patient plasma was found to be a promising biomarker for HPV...

Full description

Saved in:

Bibliographic Details
Main Authors:	Andrea Migliorelli, Andrea Ciorba, Marianna Manuelli, Francesco Stomeo, Stefano Pelucchi, Chiara Bianchini
Format:	Article
Language:	English
Published:	MDPI AG 2024-11-01
Series:	Diagnostics
Subjects:	ctHPVDNA OPSCC liquid biopsy
Online Access:	https://www.mdpi.com/2075-4418/14/23/2662
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Expression of CK7, CK19 and p16 in HPV-mediated oropharyngeal squamous cell carcinoma
by: Qizhang Yan, et al.
Published: (2024-11-01)

Pre-CCRT 18-fluorodeoxyglucose PET-CT improves survival in patients with advanced stages p16-negative oropharyngeal squamous cell carcinoma via accurate radiation treatment planning
by: Tsung-Ming Chen, et al.
Published: (2023-02-01)

Artificial intelligence for image recognition in diagnosing oral and oropharyngeal cancer and leukoplakia
by: Benedikt Schmidl, et al.
Published: (2025-01-01)

Circulating tumor DNA as a therapeutic approach for HPV (+) oropharyngeal squamous cell carcinoma
by: Raghul Murugan
Published: (2024-09-01)

Transformative advancements in immune checkpoint inhibitor therapy for Oropharyngeal Squamous Cell Carcinoma (OPSCC)
by: Iadalin Ryntathiang, et al.
Published: (2024-09-01)

Persistent oral HPV infections – Are we vaccinating against the right HPV types to prevent HPV-related oropharyngeal cancer?
by: Annika Antonsson
Published: (2024-06-01)

Distinguishing between HPV-Associated Metastatic Anal Squamous Cell Cancer and HPV-Associated Oropharyngeal Cancer
by: Steven Sorscher
Published: (2020-01-01)

Circulating tumor DNA in clinical trials for solid tumors: Challenges and current applications
by: Claudia Parisi, et al.
Published: (2023-09-01)

Liquid biopsy: Cell-free DNA based analysis in breast cancer
by: Konstantinos Venetis, et al.
Published: (2023-09-01)

The radiological features of HPV-positive vs HPV-negative OPSCC at a South African hospital
by: Anand Naranbhai, et al.
Published: (2024-11-01)

Circulating tumor DNA in diffuse large B-cell lymphoma: analysis of response assessment, correlation with PET/CT and clone evolution
by: Guilherme Duffles, et al.
Published: (2024-12-01)

The role of circulating tumor DNA in melanomas of the uveal tract
by: Mohammed Zeeshan Zameer, et al.
Published: (2024-12-01)

STOP HPV study protocol: a nationwide case–control study of the association between oropharyngeal cancer and human papillomavirus (HPV) infection in Brazil
by: Juliana Comerlato, et al.
Published: (2020-01-01)

Impact of CT texture analysis on complication rate in CT-guided liver biopsies
by: Maike Niebur, et al.
Published: (2024-01-01)

Adjuvant radiation vs Chemoradiation in HPV+ oropharyngeal squamous cell carcinoma with extranodal extension
by: Samer T. Elsamna, et al.
Published: (2022-03-01)

5-Aza-2′-deoxycytidin (Decitabine) increases cancer-testis antigen expression in head and neck squamous cell carcinoma and modifies immune checkpoint expression, especially in CD39-positive CD8 and CD4 T cells
by: Adrian Fehn, et al.
Published: (2025-01-01)

Early detection and rapid diagnosis of circulating HPV-DNA detected using droplet digital PCR
by: Mohamed Imath, et al.
Published: (2024-09-01)

Predicting the risk of high-grade precancerous cervical lesions based on high-risk HPV typing in Changsha China
by: Yaling Xiao, et al.
Published: (2025-01-01)

Prognostic stratification of oropharyngeal cancer patients in a betel nut chewing and low HPV area
by: Huai-Pao Lee, et al.
Published: (2023-04-01)

Awareness HPV causes oropharyngeal cancer and perceptions about cancer prevention among US adults
by: Onyema Greg Chido-Amajuoyi, et al.
Published: (2025-12-01)

The effect of smoking on the immediate effectiveness of induction chemotherapy in the combined treatment of HPV-associated oropharyngeal cancer
by: P. V. Golubev, et al.
Published: (2023-09-01)

Risk of residual/recurrent cervical diseases in HPV-positive women post-conization depends on HPV integration status
by: Wenyu Lin, et al.
Published: (2025-01-01)

The molecular mechanisms of increased radiosensitivity of HPV-positive oropharyngeal squamous cell carcinoma (OPSCC): an extensive review
by: Changxing Liu, et al.
Published: (2018-09-01)

HPV16 genome structure analysis in oropharyngeal cancer PDXs identifies tumors with integrated and episomal genomes
by: Claire D. James, et al.
Published: (2024-12-01)

Identification of HPV16 E1 and E2-specific T cells in the oropharyngeal cancer tumor microenvironment
by: Christine McInnis, et al.
Published: (2023-03-01)

Potential of circulating tumour DNA as a biomarker in liquid biopsy
by: Dimitar Dimitrov, et al.
Published: (2023-03-01)

Identification of Malignancy-Associated Changes in Histologically Normal Tumor-Adjacent Epithelium of Patients with HPV-Positive Oropharyngeal Cancer
by: James Jabalee, et al.
Published: (2018-01-01)

Treatment and Prevention of HPV-Associated Skin Tumors by HPV Vaccination
by: Thomas Meyer, et al.
Published: (2024-12-01)

Determining the Knowledge Levels of University Students About HPV and HPV Vaccine
by: Ayşe Dost, et al.
Published: (2024-12-01)

Intratumor heterogeneity of HPV integration in HPV-associated head and neck cancer
by: Noah Sasa, et al.
Published: (2025-01-01)

Transmission reduction and prevention with HPV vaccination (TRAP-HPV) study protocol: a randomised controlled trial of the efficacy of HPV vaccination in preventing transmission of HPV infection in heterosexual couples
by: François Coutlée, et al.
Published: (2020-08-01)

Circulating tumor DNA (ctDNA) Detection via electrochemical Biosensing Tools
by: Sonya Sahin, et al.
Published: (2024-06-01)

Liquid biopsy for monitoring minimal residual disease in localized and locally-advanced non-small cell lung cancer after radical-intent treatment
by: Héctor Aguilar, et al.
Published: (2024-06-01)

Correction: Transmission reduction and prevention with HPV vaccination (TRAP-HPV) study protocol: a randomised controlled trial of the efficacy of HPV vaccination in preventing transmission of HPV infection in heterosexual couples
Published: (2020-08-01)

Harnessing liquid biopsies: Exosomes and ctDNA as minimally invasive biomarkers for precision cancer medicine
by: Oluwaseun Adebayo Bamodu, et al.
Published: (2023-12-01)

Economic consequences of the implementation of primary DNA-HPV genotype testing in Bulgaria
by: Maria Dimitrova, et al.
Published: (2024-12-01)

Circulating tumor DNA fraction predicts residual cancer burden post-neoadjuvant chemotherapy in triple negative breast cancer
by: Naing Lin Shan, et al.
Published: (2024-12-01)

Circulating tumor DNA for surveillance in high-risk melanoma patients: a study protocol
by: Magnús P.B. Obinah, et al.
Published: (2025-02-01)

Establishment of liquid biopsy procedure for the analysis of circulating cell free DNA, exosomes, RNA and proteins in colorectal cancer and adenoma patients
by: Andrea Čeri, et al.
Published: (2024-11-01)

Pre-procedure 18F-FDG PET/CT imaging improves the performance of CT-guided transthoracic biopsy
by: Ai-Fang Jin, et al.
Published: (2024-11-01)